Pharmafile Logo

Streamlining Asynchronous Feedback: Scale Consistency – Impetus InSite Tips #2

Uncover the second crucial tip for optimizing your asynchronous virtual meetings. Learn the importance of scale consistency in survey-style questions on the Impetus InSite Platform to ensure clear and reliable participant feedback.

- PMLiVE

Uncover the second crucial tip for optimizing your asynchronous virtual meetings. Learn the importance of scale consistency in survey-style questions on the Impetus InSite Platform to ensure clear and reliable participant feedback.

2. Be Consistent When Using Scales

Achieve clarity and prevent confusion in your surveys by maintaining consistent scale increments across all questions. This quick guide highlights the significance of uniformity in scale usage and the pitfalls of inverting scale meanings between questions. Discover how straightforward, consistent scales can significantly enhance the accuracy and usefulness of the feedback you receive.

This video is part of our series on fine-tuning your asynchronous virtual meetings for maximum efficiency and participant engagement.

For a comprehensive understanding of how to enhance your virtual interactions and for more invaluable tips, follow our series and explore our blog: https://www.impetusdigital.com/2020/05/12/top-10-tips-for-optimizing-asynchronous-virtual-meetings/

 

Engage deeper with Impetus Digital:

Visit us for more insights: www.impetusdigital.com
Book a discovery call: meetwithimpetus.com/

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

The Future of Wearable and Implantable Devices

Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....

Designing Ethical AI and Healthcare Technologies

Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

Importance of Patient Advocacy in Improving Healthcare

Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...

Improving Patient Care by Removing Barriers to Drug Accessibility

Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...

Reimagining the Patient Journey

Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient...

Environmental impact of in-person vs. virtual meetings

Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...

Leadership Lessons Learned from the Pandemic

Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health...

Overcoming Behavioral Health Access Limitations Through Telemedicine

Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health...

Commercial Execution Strategies During & After the Pandemic

Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons...